The biology of ST2: The international ST2 consensus panel

American Journal of Cardiology

Volumn 115, Issue 7, 2015, Pages 3B-7B

  Pascual Figal, Domingo A ^a   Januzzi, James L ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 33; ST2 PROTEIN; ST2L PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE; CONSENSUS; DISEASE COURSE; FIBROBLAST; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; STRESS; METABOLISM; PATHOLOGY;

APOPTOSIS; CARDIOVASCULAR DISEASES; CONSENSUS; HUMANS; MYOCYTES, CARDIAC; RECEPTORS, CELL SURFACE;

EID: 84924977608     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.01.034     Document Type: Article

References (23)

1. S. Tominaga A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor FEBS Lett 258 1989 301 304
2. R. Klemenz, S. Hoffmann, and A.K. Werenskiold Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen Proc Natl Acad Sci U S A 86 1989 5708 5712
3. E.O. Weinberg, M. Shimpo, Keulenaer GW. De, C. MacGillivray, S. Tominaga, S.D. Solomon, J.-L. Rouleau, and R.T. Lee Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction Circulation 106 2002 2961 2966
4. J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy, T.K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, D.M. Gorman, J.F. Bazan, and R.A. Kastelein IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
5. G. Bergers, A. Reikerstorfer, S. Braselmann, P. Graninger, and M. Busslinger Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor EMBO J 13 1994 1176 1188
6. Y. Baba, K. Maeda, T. Yashiro, E. Inage, K. Kasakura, R. Suzuki, F. Niyonsaba, M. Hara, A. Tanabe, H. Ogawa, K. Okumura, Y. Ohtsuka, T. Shimizu, and C. Nishiyama GATA2 is a critical transactivator for the human IL1RL1/ST2 promoter in mast cells/basophils: opposing roles for GATA2 and GATA1 in human IL1RL1/ST2 gene expression J Biol Chem 287 2012 32689 32696
7. A. Caporali, M. Meloni, A.M. Miller, K. Vierlinger, A. Cardinali, G. Spinetti, A. Nailor, E. Faglia, S. Losa, A. Gotti, O. Fortunato, T. Mitic, M. Hofner, C. Noehammer, P. Madeddu, and C. Emanueli Soluble ST2 is regulated by p75 neurotrophin receptor and predicts mortality in diabetic patients with critical limb ischemia Arterioscler Thromb Vasc Biol 32 2012 e149 e160
8. J.E. Ho, W.-Y. Chen, M.-H. Chen, M.G. Larson, E.L. McCabe, S. Cheng, A. Ghorbani, E. Coglianese, V. Emilsson, A.D. Johnson, S. Walter, N. Franceschini, C.J. O'Donnell, A. Dehghan, C. Lu, D. Levy, C. Newton-Cheh, H. Lin, J.F. Felix, E.R. Schreiter, R.S. Vasan, J.L. Januzzi, R.T. Lee, T.J. Wang, T.L. Assimes, P. Deloukas, J. Erdmann, H. Holm, S. Kathiresan, I.R. König, R. McPherson, M.P. Reilly, R. Roberts, N.J. Samani, H. Schunkert, and A.F.R. Stewart Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling J Clin Invest 123 2013 4208 4218
9. R. Kakkar, and R.T. Lee The IL-33/ST2 pathway: therapeutic target and novel biomarker Nat Rev Drug Discov 7 2008 827 840
10. R. Kakkar, H. Hei, S. Dobner, and R.T. Lee Interleukin 33 as a mechanically responsive cytokine secreted by living cells J Biol Chem 287 2012 6941 6948
11. A.A. Chackerian, E.R. Oldham, E.E. Murphy, J. Schmitz, S. Pflanz, and R.A. Kastelein IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex J Immunol 179 2007 2551 2555
12. A. Schmieder, G. Multhoff, and J. Radons Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells Cytokine 60 2012 514 521
13. S. Sanada, D. Hakuno, L.J. Higgins, E.R. Schreiter, A.N.J. McKenzie, and R.T. Lee IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system J Clin Invest 117 2007 1538 1549
14. J. Sanchez-Mas, A. Lax, M. Asensio-Lopez, M. Fernandez-Del Palacio, L. Caballero, G. Santarelli, J. Januzzi, and D. Pascual-Figal Modulation of IL-33/ST2 system in post-infarction heart failure: correlation with cardiac remodeling markers Eur J Clin Invest 2014
15. R.A.P. Weir, A.M. Miller, G.E.J. Murphy, S. Clements, T. Steedman, J.M.C. Connell, I.B. McInnes, H.J. Dargie, and J.J.V. McMurray Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction J Am Coll Cardiol 55 2010 243 250
16. R.V. Shah, A.A. Chen-Tournoux, M.H. Picard, Kimmenade RRJ van, and J.L. Januzzi Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea Circ Heart Fail 2 2009 311 319
17. J.L. Januzzi, W.F. Peacock, A.S. Maisel, C.U. Chae, R.L. Jesse, A.L. Baggish, M. O'Donoghue, R. Sakhuja, A.A. Chen, Kimmenade RRJ van, K.B. Lewandrowski, D.M. Lloyd-Jones, and A.H.B. Wu Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study J Am Coll Cardiol 50 2007 607 613
18. K. Seki, S. Sanada, A.Y. Kudinova, M.L. Steinhauser, V. Handa, J. Gannon, and R.T. Lee Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling Circ Heart Fail 2 2009 684 691
19. A. Yndestad, A.K. Marshall, J.D. Hodgkinson, E.L. Tham, P.H. Sugden, and A. Clerk Modulation of interleukin signalling and gene expression in cardiac myocytes by endothelin-1 Int J Biochem Cell Biol 42 2010 263 272
20. A. Lax, J. Sanchez-Mas, M. Asensio-Lopez, M. Fernandez-Del Palacio, L. Caballero, I. Garrido, F. Pastor, J. Januzzi, and D. Pascual-Figal Mineralocorticoid receptor antagonists modulate galectin-3 and IL-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction JACC Hear Fail 3 2015 50 58
21. J. Bartunek, L. Delrue, F. Van Durme, O. Muller, F. Casselman, B. De Wiest, R. Croes, S. Verstreken, M. Goethals, H. de Raedt, J. Sarma, L. Joseph, M. Vanderheyden, and E.O. Weinberg Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load J Am Coll Cardiol 52 2008 2166 2174
22. S. Demyanets, C. Kaun, R. Pentz, K.A. Krychtiuk, S. Rauscher, S. Pfaffenberger, A. Zuckermann, A. Aliabadi, M. Gröger, G. Maurer, K. Huber, and J. Wojta Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature J Mol Cell Cardiol 60 2013 16 26
23. A.M. Miller, D. Xu, D.L. Asquith, L. Denby, Y. Li, N. Sattar, A.H. Baker, I.B. McInnes, and F.Y. Liew IL-33 reduces the development of atherosclerosis J Exp Med 205 2008 339 346